Linaclotide Stocks List

Recent Signals

Date Stock Signal Type
2021-02-25 AZN Stochastic Reached Oversold Weakness
2021-02-25 IRWD Lower Bollinger Band Walk Weakness

Recent News for Linaclotide Stocks

Date Stock Title
Feb 26 AZN Vaccine Stocks Drop With J&J Set to Release Third U.S. Shot
Feb 26 AZN CLASS ACTION UPDATE for AZN, EH and EBIX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Feb 26 AZN INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AstraZeneca PLC and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Feb 26 AZN Health Canada authorizes AstraZeneca COVID-19 vaccine
Feb 26 AZN How does the Johnson & Johnson COVID-19 vaccine compare with the Pfizer and Moderna shots?
Feb 26 AZN AstraZeneca and Amgen's tezepelumab successful in phase 3 for severe asthma
Feb 26 AZN AstraZeneca-Amgen drug could widen treatment options for severe asthma
Feb 26 AZN Tezepelumab Is the First Biologic to Consistently and Significantly Reduce Exacerbations in Broad Population of Severe Asthma Patients
Feb 26 AZN UPDATE 1-Canada approves AstraZeneca's COVID-19 vaccine
Feb 26 AZN UPDATE 1-Indians allowed to choose vaccination sites as govt seeks faster roll-out
Feb 26 AZN Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg
Feb 26 AZN Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning
Feb 26 AZN UPDATE 1-Vietnam says panel recommends Sputnik V, Moderna vaccines for use
Feb 26 AZN FOCUS-AstraZeneca, Sputnik vaccines face hurdles if COVID shots become annual affair
Feb 26 AZN UPDATE 2-South Korea kicks off COVID-19 vaccination campaign
Feb 25 AZN Ecuador signs agreement with Sinovac for 2 million COVID-19 vaccine: minister
Feb 25 AZN AZN Breaking Alert: Rosen, A Leading Law Firm, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline - AZN
Feb 25 AZN ‘Covid-19 has been the perfect storm for adversaries’ in cybersecurity industry: CrowdStrike
Feb 25 AZN Doctor: New COVID-19 strains come from ‘robust transmission of the virus’
Feb 25 AZN AstraZeneca looking at its global supply chain to address COVID-19 vaccine shortfall

Linaclotide (marketed under the trade name Linzess in the US and Mexico, and as Constella elsewhere) is a drug used to treat irritable bowel syndrome with constipation and chronic constipation with no known cause.
It has a black box warning about the risk of serious dehydration in children in the US; the most common adverse effects in others are gastrointestinal.It is an oligo-peptide agonist of guanylate cyclase 2C and remains in the GI tract after it is taken orally. It was approved in the US and Europe in 2012.It is priced at around $400 for thirty pills in the US and is marketed by Allergan in most of the world and by Astellas in Asia; Ironwood Pharmaceuticals was the originator.

More about Linaclotide
Browse All Tags